Mosaic ImmunoEngineering Inc.
CPMV· OTC
CPMVMosaic ImmunoEngineering Inc.
Filed May 14, 2024 · 10-Q · 44 days after period end · 0001683168-24-003375
| Metric | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|
| Net Income | -$288.49K | -$399.04K | -$763.48K | -$806.84K |
| EPS Diluted | -$0.04 | -$0.06 | -$0.11 | -$0.15 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Mosaic ImmunoEngineering Inc. · CIK 836564 · Engraved from SEC EDGAR
ended Mar 31, 2024 · filed May 14, 2024 · 44 d after period end
